Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A severe but reversible refractory sprue.

Literature DB >> 16849355

A severe but reversible refractory sprue.

X Dray, F Joly, A Lavergne-Slove, X Treton, Y Bouhnik, B Messing.

Abstract

Mesh：

Substances：

Year: 2006 PMID： 16849355 PMCID： PMC1856279 DOI： 10.1136/gut.2005.089987

Source DB: PubMed Journal: Gut ISSN： 0017-5749 Impact factor: 23.059

× No keyword cloud information.

12 in total

1. Role of immunosuppressive therapy in refractory sprue-like disease.

Authors: P Rolny; H A Sigurjonsdottir; H Remotti; L A Nilsson; H Ascher; H Tlaskalova-Hogenova; L Tuckova
Journal: Am J Gastroenterol Date: 1999-01 Impact factor: 10.864

2. A pilot study of recombinant human interleukin-10 in adults with refractory coeliac disease.

Authors: C J Mulder; P J Wahab; J W Meijer; E Metselaar
Journal: Eur J Gastroenterol Hepatol Date: 2001-10 Impact factor: 2.566

3. Successful treatment of refractory sprue with cyclosporine.

Authors: G F Longstreth
Journal: Ann Intern Med Date: 1993-11-15 Impact factor: 25.391

4. Cyclosporin in the treatment of adults with refractory coeliac disease--an open pilot study.

Authors: P J Wahab; J B Crusius; J W Meijer; J J Uil; C J Mulder
Journal: Aliment Pharmacol Ther Date: 2000-06 Impact factor: 8.171

5. Successful infliximab treatment for steroid-refractory celiac disease: a case report.

Authors: Helen R Gillett; Ian D R Arnott; Margaret McIntyre; Simon Campbell; Anna Dahele; Matthew Priest; Robert Jackson; Subrata Ghosh
Journal: Gastroenterology Date: 2002-03 Impact factor: 22.682

6. Pentostatin (2'-deoxycoformycin) for the treatment of hepatosplenic gammadelta T-cell lymphomas.

Authors: Gaetano Corazzelli; Gaetana Capobianco; Filippo Russo; Ferdinando Frigeri; Donatella Aldinucci; Antonio Pinto
Journal: Haematologica Date: 2005-03 Impact factor: 9.941

7. Plasma citrulline: A marker of enterocyte mass in villous atrophy-associated small bowel disease.

Authors: Pascal Crenn; Kouroche Vahedi; Anne Lavergne-Slove; Luc Cynober; Claude Matuchansky; Bernard Messing
Journal: Gastroenterology Date: 2003-05 Impact factor: 22.682

8. An update: 12-year follow-up of patients with hairy cell leukemia following treatment with 2-chlorodeoxyadenosine.

Authors: U Jehn; R Bartl; H Dietzfelbinger; T Haferlach; V Heinemann
Journal: Leukemia Date: 2004-09 Impact factor: 11.528

Review 9. Pentostatin (Nipent) in the treatment of chronic lymphocyte leukemia and hairy cell leukemia.

Authors: Robert O Dillman
Journal: Expert Rev Anticancer Ther Date: 2004-02 Impact factor: 4.512

10. Azathioprine and prednisone combination therapy in refractory coeliac disease.

Authors: M S Goerres; J W R Meijer; P J Wahab; J A M Kerckhaert; P J T A Groenen; J H J M Van Krieken; C J J Mulder
Journal: Aliment Pharmacol Ther Date: 2003-09-01 Impact factor: 8.171

9 in total

Review 1. Classification and management of refractory coeliac disease.

Authors: Alberto Rubio-Tapia; Joseph A Murray
Journal: Gut Date: 2010-04 Impact factor: 23.059

Review 2. Refractory celiac disease: from bench to bedside.

Authors: Georgia Malamut; Bertrand Meresse; Christophe Cellier; Nadine Cerf-Bensussan
Journal: Semin Immunopathol Date: 2012-07-19 Impact factor: 9.623

Review 3. The spectrum of celiac disease: epidemiology, clinical aspects and treatment.

Authors: Greetje J Tack; Wieke H M Verbeek; Marco W J Schreurs; Chris J J Mulder
Journal: Nat Rev Gastroenterol Hepatol Date: 2010-03-09 Impact factor: 46.802

Review 4. Inflammatory bowel disease and celiac disease: overlaps and differences.

Authors: Virginia Pascual; Romina Dieli-Crimi; Natalia López-Palacios; Andrés Bodas; Luz María Medrano; Concepción Núñez
Journal: World J Gastroenterol Date: 2014-05-07 Impact factor: 5.742

Review 5. Refractory Celiac Disease.

Authors: Isabel A Hujoel; Joseph A Murray
Journal: Curr Gastroenterol Rep Date: 2020-03-17